Records containing: Neoplasms, Lung

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-22
Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), Compared With Topotecan in Participants With Relapsed Small Cell Lung Cancer (SCLC)
CLINICAL_TRIALS study record update · 2026-03-18
A Phase Ib/II Open-label, Multi-center Dose Escalation Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
CLINICAL_TRIALS study record update · 2026-02-23
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
CLINICAL_TRIALS study record update · 2025-10-14
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
CLINICAL_TRIALS study record update · 2025-09-12
An Open-Label, Multiple Dose, Dose Escalation and Cohort Expansion Phase I/II Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of ESG401 in Subjects With Locally Advanced/Metastatic Solid Tumors
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2023-10-10
Feasibility and Acceptability of Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
CLINICAL_TRIALS study record update · 2023-10-04
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
CLINICAL_TRIALS study record update · 2022-09-28
A Phase I Study of iPS Cell Generation From Patients With COPD
CLINICAL_TRIALS study record update · 2021-07-21
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
CLINICAL_TRIALS study record update · 2020-12-21
A Multicenter Study of the NEUWAVE Flex Microwave Ablation System in the Ablation of Medically Inoperable Primary Soft Tissue Lesions of the Lung: An Initial Experience
CLINICAL_TRIALS study record update · 2020-06-02
A Multicenter Study of the NEUWAVE Flex Microwave Ablation System in the Ablation of Secondary Soft Tissue Lesions of the Lung
CLINICAL_TRIALS study record update · 2019-09-12
Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic of the Nasopharynx
CLINICAL_TRIALS study record update · 2018-03-21
A Pilot Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
CLINICAL_TRIALS study record update · 2015-06-03
Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic Adenocarcinoma of the Lung
CLINICAL_TRIALS study record update · 2012-12-10
A Multicenter, Open-label, Single-arm, Two-stage Study of the Efficacy and Safety of AVE0005 (VEGF Trap) Administered Intravenously Every 2 Weeks in Patients With Platinum- and Erlotinib-resistant Locally Advanced or Metastatic Non-small-cell Lung Adenocarcinoma
CLINICAL_TRIALS study record update · 2010-05-27
Survival Analysis of A Chinese Randomized Crossover Study Comparing Erlotinib to Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations
CLINICAL_TRIALS study record update · 2009-07-09
Incidence of Postthoracotomy Pain Following General Anesthesia: A Comparison Between TIVA and Inhalation Anesthesia
CLINICAL_TRIALS study record update · 2007-06-08
A Phase 3, Randomized, Double-Blind, Multicenter Study of Talabostat and Pemetrexed vs. Pemetrexed and Placebo in Patients With Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
CLINICAL_TRIALS study record update · 2006-07-19
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.